Search

Author/Creator Hansen, Svend Høime

2. Bile acid–farnesoid X receptor–fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial. Issue 4 (1st September 2021)

Authors:
Hvistendahl, Mark Krogh; Naimi, Rahim Mohammad; Hansen, Svend Høime; Rehfeld, Jens Frederik; Kissow, Hannelouise; Pedersen, Jens; Dragsted, Lars Ove; Sonne, David Peick; Knop, Filip Krag; Jeppesen, Palle Bekker
Journal:
JPEN, Journal of parenteral and enteral nutrition
Issue:
Volume 46:Issue 4(2022)
Page Start:
923
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cholestasis alters brain lipid and bile acid composition and compromises motor function in neonatal piglets. Issue 13 (12th July 2022)

Authors:
Henriksen, Nicole Lind; Hansen, Svend Høime; Lycas, Matthew Domenic; Pan, Xiaoyu; Eriksen, Thomas; Johansen, Lars Søndergaard; Sprenger, Richard R.; Ejsing, Christer Stenby; Burrin, Douglas G.; Skovgaard, Kerstin; Christensen, Vibeke Brix; Thymann, Thomas; Pankratova, Stanislava
Journal:
Physiological reports
Issue:
Volume 10:Issue 13(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial. (April 2023)

Authors:
Borup, Christian; Vinter-Jensen, Lars; Jørgensen, Søren Peter German; Wildt, Signe; Graff, Jesper; Gregersen, Tine; Zaremba, Anna; Borup Andersen, Trine; Nøjgaard, Camilla; Timm, Hans Bording; Rainteau, Dominique; Hansen, Svend Høime; Rumessen, Jüri Johannes; Munck, Lars Kristian
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 8:Number 4(2023)
Page Start:
321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗